
EuroPCR 2023: Improving outcomes in mitral regurgitation
Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.
Related Videos

EuroPCR 2023: COAPT 5-year follow-up

EuroPCR 2023: Vascular access

EuroPCR 2023: Defining the future

EuroPCR 2023: Tricuspid valve

Navitor™: Voice of the Experts Mohammed Saad

TAVI webinar: new implantation technique

Navitor™: Voice of the Experts Federico de Marco

EACVI Summit 2023: Congress symposium

Transcatheter Mitral Valve implant

Safety with TriClip TEER

Mechanical Heart Valve Patient Story: Javier